ProCE Banner Activity

Recent Updates in the Management of Relapsed/Refractory Follicular Lymphoma

Slideset Download

Download this slideset from a live CCO webinar for an expert overview of recent updates in R/R FL with a focus on second-line therapies and third-line epigenetic modifiers and PI3K inhibitors, including data from ASH 2022.

Released: February 02, 2023

Expiration: February 01, 2024



Ian Flinn

Ian Flinn, MD, PhD

Chief Scientific Officer
Nashville, Tennessee

Laurie H. Sehn

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Genentech, a member of the Roche Group

MEI Pharma Inc